Acetate or palmitate: choosing a vitamin A grade
Retinyl acetate and retinyl palmitate are both vitamin A esters, but they are not interchangeable gram for gram: the acetate carries more retinol per gram, the palmitate is more lipophilic, and the label names whichever ester is used. The 500,000 IU/g spray-dried acetate is built for dry blends, while an oil or an emulsion may suit the palmitate better. A switch changes the IU density, the carrier load, the stability file and the ingredient declaration. The ester is therefore a formulation decision before it is a purchasing one.
Acetate and palmitate are different esters with different masses, so the grade is chosen by IU density, dosage form and label name, not by the IU figure alone.
Why the ester is the first decision
A vitamin A specification that stops at “500,000 IU/g” does not identify the material. The same IU figure can be reached with retinyl acetate, retinyl palmitate or a blend, at different dilution rates, in different carriers. The ester sets the molecular mass, the amount of powder needed for a dose, the behaviour in oil and the name that appears on the label. Those four consequences are why the ester belongs in the first line of the specification, not in a footnote.
Both esters are hydrolysed to retinol in the same way for the IU calculation, so the arithmetic of the label is shared. The physical material is not. A formulator who compares two quotations on IU/g alone is comparing a number, not a raw material.
The two esters side by side
| Property | Retinyl acetate | Retinyl palmitate |
|---|---|---|
| CAS | 127-47-9 | 79-81-2 |
| Formula and mass | C22H32O2 · 328.49 g/mol | C36H60O2 · 524.86 g/mol |
| Retinol per gram of pure ester | About 872 mg/g | About 546 mg/g |
| Pure ester potency | About 2.9 million IU/g | About 1.8 million IU/g |
| Ester in a 500,000 IU/g powder | About 17% by mass | About 27% by mass |
| Lipophilicity | Lower; more crystalline | Higher; oily or waxy |
| Usual presentation | Spray-dried powder, oil | Oil, emulsion, spray-dried powder |
| Ingredient name | Retinyl acetate | Retinyl palmitate |
The mass difference is the reason for the dilution difference. One gram of pure retinyl acetate carries about 2.9 million IU, so a 500,000 IU/g powder is roughly one part ester to five parts matrix. Palmitate carries about 1.8 million IU/g, so the same 500,000 IU/g grade needs about 27% ester and less carrier. The palmitate powder therefore contains more ester mass for the same IU figure, which matters when the dose is weighed or when the carrier contribution has to stay low.
What changes in the powder
Retinyl acetate is a crystalline solid; retinyl palmitate is an oil or a waxy solid at room temperature. That difference drives the powder technology. An acetate grade is usually spray-dried into a free-flowing matrix and sieved to a declared mesh; a palmitate grade is more often emulsified before drying, because the oil has to be dispersed in the carrier. The two powders can look similar and behave differently in a blender.
Stability follows the same split. The dry acetate powder is protected by the matrix and the pack, while an oil or emulsion exposes the ester to dissolved oxygen, light and the carrier oil's own oxidation. A palmitate solution is not automatically the more stable option; the matrix and the pack decide.
On a switch, check bulk density, flow, dispersion in warm water, particle-size distribution and segregation in a dry blend. A powder that flows well in one carrier can bridge in a tablet hopper in another. Compression behaviour, capsule fill weight and blend uniformity are formulation tests, not certificate lines, and they belong in the trial rather than in the purchase order.
Matching the ester to the dosage form
For tablets and capsules, the dry acetate powder is the straightforward choice: it is free-flowing, sieved to 40 mesh and carries the vitamin in a matrix that can be blended. For a softgel or an oil, the palmitate is more soluble in the oil phase, while an acetate oil can also be used if the formula and the stability data support it. For an emulsion, a gummy or a fortified beverage, the decision turns on how the vitamin is dispersed and how much heat the process applies, not on the ester name alone.
The process conditions belong in the comparison. A powder added at the end of a dry blend sees little heat; a vitamin added before a cook or a pasteurisation step sees more. The same ester can be a good choice in one process and a poor one in another. Ask for stability data in the intended matrix rather than assuming that a raw-material result transfers.
What to write in the specification
A complete line reads: retinyl acetate, 500,000 IU/g by HPLC, carrier gelatin, sucrose and starch, loss on drying ≤5.0%, ≥95% through 40 mesh, with the heavy-metal and micro panels stated. The ester name, the IU/g, the method and the carrier are the four parts that make the line usable. Add the gelatin source, any declared antioxidant, the IU basis and the overage policy if the formula depends on them.
- Name the ester, not just “vitamin A”.
- State the IU/g and the method behind it.
- Name the carrier and its proportions where they affect the label.
- State the gelatin source and any allergen consequence.
- State the loss on drying, the mesh and the contaminant panels.
- State whether an antioxidant is present and how it is declared.
A switch from acetate to palmitate is a new specification, a new certificate and a new label. The old stability file does not carry over, because the matrix, the dose weight and the degradation profile have changed.
When not to switch
Do not switch ester to close a quotation gap alone. The two materials differ in potency density, so a “same IU” swap changes the weight of powder in the formula, the carrier load and possibly the tablet or capsule size. If the label already names one ester, a switch also requires a new ingredient declaration and a new artwork cycle.
A switch is reasonable when the dosage form demands it, when the current ester is not available in the grade or carrier needed, or when the stability data shows a real advantage in the intended matrix. In each case, ask for the new certificate, the chromatogram, the carrier declaration and a stability summary before the first production batch. The vitamin A product page carries the catalog specification; the COA page explains how the IU and carrier are reported; the stability page covers the storage and process variables; and the acetate versus palmitate page sets out the detailed comparison. The assay glossary entry defines the result basis.
In this document
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation